Amyloid Hypothesis gaining strengthCouple of takeaways for me today:
1). With Acumen clinical results, the Amyloid hypothesis continues to be gaining strength (Biogen, Lilly & now Acumen with recent positive clinical results). I think that helps everyone in this ecosystem, including Promis. Increases the likelihood of pharma investing in these companies.
2). Huge volume today, including big volume buys. The question is who are these "investors"? As someone mentioned earlier, were Insiders buying today? Obviously, there will be traders who will be in and out. But, hopefully, we got "new" big investors today who are here for the long-term.
Congrats to Longs.